Abstract: The present disclosure provides a method, device, and electronic device for controlling 3D printing. The method comprises: controlling a 3D printing device to print based on the preset printing parameters by a preset printing control strategy to obtain printing results; monitoring the printing environment, printing structure, and the printing results by a monitor to obtain the corresponding monitoring information; adjusting the preset printing parameters based on the monitoring information by a printing feedback control strategy to obtain adjusted results of the printing parameters; time-programing the printing results to position printing based on the monitoring information using a spatiotemporal recombination control strategy to obtain printing results of spatiotemporal positioning control.

Abstract: A cup lid that facilitates convenient operation by allowing effort saving opening of a water passing hole by using only one hand, wherein the cup lid has a main lid and an auxiliary lid; an upper surface of the main lid has the water passing hole and an air vent; the auxiliary lid is rotatably mounted on the upper surface of the main lid, and being axially limited with respect to the main lid. Rotation of the auxiliary lid will cause a water passing port disposed thereon to open or close the water passing hole; the auxiliary lid also has an air guide slot in which the air vent can slide therein when the auxiliary lid rotates, and the air guide slot is in communication with an external environment. A container using the cup lid is also provided.

Abstract: Claudin 18.2 T cell antigen couplers (TACs) polypeptides having (i) an antigen-binding domain that binds Claudin 18.2, (ii) an antigen-binding domain that binds a protein associated with a TCR complex, and (iii) a T cell receptor signaling domain polypeptide are provided. Nucleic acids encoding the claudin 18/2 TACs are also provided.

Abstract: Provided are three-dimensional forming method and system. The method includes: controlling, by acoustic wave, bio-ink in acoustic resonant cavity to form cell cluster pattern M1; performing controllable photocuring on pre-curing position of the cell cluster pattern M1, to obtain cured formed structure; transferring the cured formed structure; controlling, by acoustic wave, the bio-ink in the acoustic resonant cavity to form cell cluster pattern M2, and adjusting the position, in the bio-ink, of the cured formed structure, such that the position is accurately joined with pre-curing position of the cell cluster pattern M2; performing controllable photocuring on the pre-curing position of the cell cluster pattern M2, to obtain cured formed structure; and circularly executing steps 3-5 a preset number of times, to obtain the three-dimensional tissue structure.

Abstract: Provided herein are KRAS G12C and KRAS G12D inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Abstract: A method for hardware management of DMA transfer commands includes accessing, by a first DMA engine, a DMA transfer command and determining a first portion of a data transfer requested by the DMA transfer command. Transfer of a first portion of the data transfer by the first DMA engine is initiated based at least in part on the DMA transfer command. Similarly, a second portion of the data transfer by a second DMA engine is initiated based at least in part on the DMA transfer command. After transferring the first portion and the second portion of the data transfer, an indication is generated that signals completion of the data transfer requested by the DMA transfer command.

Abstract: Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Abstract: A support base includes a connector hub having a top end, a bottom end spaced apart from the top end, and a chamber wall extending between the top and bottom ends. The chamber wall defines a chamber within the connector hub. An interface may be positioned in the chamber. The interface is dimensioned such that a support gap is formed between the interface and the chamber wall. The support gap may be dimensioned for receiving a wall of a support structure having a hollow interior into which the interface is received.

Abstract: Systems, apparatuses, and methods for implementing a centralized interrupt controller to aggregate interrupts generated across multiple semiconductor dies are disclosed. A system includes multiple interrupt sources on multiple semiconductor dies. A centralized interrupt controller on one of the semiconductor dies receives and aggregates interrupts from the multiple interrupt sources on the multiple semiconductor dies. This facilitates a single transmission point for forwarding the interrupts to the processor and operating system responsible for handling interrupts. Each interrupt source embeds an ID when conveying an interrupt to the interrupt controller. This allows the interrupt controller to differentiate between the interrupt sources and to identify which source generated a given interrupt. The interrupt controller conveys an indication of the source of the interrupt to the processor when forwarding the interrupt to the processor.

Abstract: A display substrate, a display panel, and a display device are provided. The display substrate includes a substrate, a plurality of sub-pixels located on the substrate, a plurality of driving circuits and a plurality of light sensors, an orthographic projection of the light sensors on the substrate is within a range of an orthographic projection of the driving circuits on the substrate.

Abstract: Disclosed are a display panel and a display device. The display panel includes a base substrate; a plurality of data signal lines on the base substrate, and a plurality of pixel units; and each pixel unit has a transparent area and a non-transparent area; the pixel unit includes a plurality of sub-pixels in the non-transparent area. All sub-pixels in the display panel are arranged in an array, each column of sub-pixels corresponds to a respective one of the data signal lines, and at least part of the data signal lines are arranged around the transparent areas.

Abstract: A display panel and a method for adjusting brightness thereof, and a display apparatus. The display panel includes a first and a second display area. A pixel density of the first display area is less than a pixel density of the second display area. The display panel includes a power supply unit including a power supply output terminal; first power supply lines electrically connected to sub-pixels of the first display area; second power supply lines electrically connected to sub-pixels of the second display area; and a voltage adjusting unit. First ends of the second power supply lines are electrically connected to the power supply output terminal, second ends of the second power supply lines are electrically connected to the first power supply lines via the voltage adjusting unit, and the voltage adjusting unit is configured to adjust a voltage on the first power supply lines.

Abstract: Embodiments of the present disclosure provide a thin film transistor, a method of manufacturing the same, and a display device. The thin film transistor includes a metal conductive pattern layer, an interlayer insulating layer, and a metal oxide layer; and the metal conductive pattern layer includes: a light shielding pattern, a source signal line, and/or a drain signal line; the metal oxide layer includes: a source electrode, a drain electrode, and an active layer. An orthographic projection of the active layer on the base substrate has an overlapping region with that of the light shielding pattern; the source electrode extends through the interlayer insulating layer to connect to the source signal line, and/or the drain electrode extends through the interlayer insulating layer to connect to the drain signal line.

Abstract: The present invention provides a keratin BD-3, a nucleic acid molecule encoding same, an expression vector, a host cell, a preparation method therefor, and a pharmaceutical composition contained the keratin BD-3. The keratin BD-3 can be used in the preparation of medicament for antipyretic, analgesic, antitussive, expectorant, anticonvulsant, antiepileptic, anti-hypertension, anti-inflammatory, and antiviral.

Abstract: Described herein are novel PRMT5 inhibitors of Formula I and pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity and may have use in treating proliferative, metabolic and blood disorders.